Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
APTA President’s Note | The Road Ahead

May 1, 2025/Column

Learn how APTA President Kyle Covington is thinking boldly about the future and every member's role in evolving our profession.

Researcher Spotlight

May 1, 2024/Column

Julie Fritz, PT, PhD, FAPTA, shares experiences translating research into practice and being a peer reviewer.

Researcher Spotlight

Dec 1, 2024/Article

Jim Gordon, PT, EdD, FAPTA, takes stock of his research journey and the challenges that remain.

Craig Hospital Inventory of Environmental Factors (CHIEF) – Spinal Cord Injury (SCI)

Feb 2, 2014/Test & Measure

Measures degree to which elements of the physical, social, and political environments act as barriers or facilitators to full participation for people with disabilities.

Resources for Teaching Cultural Competence and Cultural Humility in Physical Therapy Education

Feb 4, 2025/Resource

Cultural competence isn't a destination; it's a journey that never stops.

Health Information Technology Advocacy

PTs and PTAs need to be part of the evolution in health information technology.

APTA Practice Update: Future of Physical Therapy Summit Preview, Impact of COVID-19 on the Physical Therapy Profession, and Telehealth News

Jun 22, 2023/Podcast

On this episode, APTA staff experts share highlights from APTA's final COVID-19 report, updates on telehealth payment, and a preview of the APTA Future of Physical Therapy Summit.

Defining Moment: Training Agents of Change

Dec 3, 2024/Podcast

Linda Robinson, PT, MSPT, volunteered in Haiti and discovered a love for teaching the country's first generation of physical therapists.

55th Mary McMillan Lecture

Feb 14, 2024/Video

Acknowledging current actions of APTA and proposed opportunities for more fully engaging with the global rehabilitation community.

Multiple Sclerosis in Adults: Management [NICE NG220]

Jun 22, 2022/CPG

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over and aims to improve the quality of life for adults with multiple sclerosis. [Formerly NICE CG186.]